Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes.

Mozhgan Dorkhan; Mikael Lantz; Anders Frid; Leif Groop; Bengt Hallengren

doi:10.1111/j.1365-2265.2006.02542.x

Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes.

Mozhgan Dorkhan, Mikael Lantz, Anders Frid, Leif Groop, Bengt Hallengren

Research output: Contribution to journal › Article › peer-review

212 Downloads (Pure)

Original language	English
Pages (from-to)	35-39
Journal	Clinical Endocrinology
Volume	65
Issue number	1
DOIs	https://doi.org/10.1111/j.1365-2265.2006.02542.x
Publication status	Published - 2006

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Diabetes and Endocrinology (013241530), Pediatrics/Urology/Gynecology/Endocrinology (013240400)

Subject classification (UKÄ)

Endocrinology and Diabetes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1365-2265.2006.02542.x

DorkhanBlackwell

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16817816&dopt=Abstract

Cite this

@article{82360e7345444df6bb10aa3c92e675d5,

title = "Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes.",

author = "Mozhgan Dorkhan and Mikael Lantz and Anders Frid and Leif Groop and Bengt Hallengren",

note = "The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Diabetes and Endocrinology (013241530), Pediatrics/Urology/Gynecology/Endocrinology (013240400)",

year = "2006",

doi = "10.1111/j.1365-2265.2006.02542.x",

language = "English",

volume = "65",

pages = "35--39",

journal = "Clinical Endocrinology",

issn = "1365-2265",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes.

AU - Dorkhan, Mozhgan

AU - Lantz, Mikael

AU - Frid, Anders

AU - Groop, Leif

AU - Hallengren, Bengt

N1 - The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Diabetes and Endocrinology (013241530), Pediatrics/Urology/Gynecology/Endocrinology (013240400)

PY - 2006

Y1 - 2006

UR - https://www.scopus.com/pages/publications/33745192492

U2 - 10.1111/j.1365-2265.2006.02542.x

DO - 10.1111/j.1365-2265.2006.02542.x

M3 - Article

C2 - 16817816

SN - 1365-2265

VL - 65

SP - 35

EP - 39

JO - Clinical Endocrinology

JF - Clinical Endocrinology

IS - 1

ER -

Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes.

Bibliographical note

Subject classification (UKÄ)

UN SDGs

Access to Document

Other files and links

Assessment and Treatment of Impaired Insulin- Secretion and Action in Type 2 Diabetes

Cite this